Medically Speaking: Marijuana & Multiple Sclerosis

Mary Jon

The column, Medically Speaking, is dedicated to providing informative articles pertaining to the medical benefits of marijuana. Every article will bring readers a wide perspective of views on whether medical marijuana is a cure & legitimate for various diseases and illnesses. Exclusive to HazeNation! – by Mary Jon

In the United States, Multiple Sclerosis is becoming quite the epidemic. About 400,000 people live with the symptoms of MS; that’s 200 new diagnoses per week. 2.1 million people suffer from Multiple Sclerosis worldwide. Medical cannabis assists patients to not cure MS, but be able to live with the debilitating effects of the disease.

Multiple Sclerosis is a disease that effects almost all aspects of the body, due to the domino effect of symptoms. Multiple sclerosis is a disease that targets a human’s nervous system. The nervous system includes the optic nerves, spinal cord and brain. According to the National MS Society, “it is thought to be an autoimmune disorder. This means the immune system incorrectly attacks the person’s healthy tissue.” The symptoms include, “blurred vision, loss of balance, poor coordination, slurred speech, tremors, numbness, extreme fatigue, problems with memory and concentration, paralysis, and blindness. These problems may be permanent or may come and go.” The effects of the disease can debilitate people living with it, so many patients turn to medical marijuana for relief.

Marijuana has proven to relieve patients of the aforementioned symptoms, but professionals say that the effects of medical marijuana on the body may be more than the relief. The primary symptoms include pain, tremor, and spasticity. The issue is a hot debate as it is still classified as an illegal drug federally. According to the National Academy of Sciences/ Institute of Medicine Report on the National MS Society, “Investigators in the United Kingdom and United States tested the ability of two marijuana derivatives and three synthetic cannabinoids to control spasticity and tremor, symptoms of the MS-like disease, EAE, in mice. The results, published in the March 2, 2000 issue of Nature, suggested that four different cannabinoids could temporarily relieve spasticity and/or tremor. While the study suggested that similar derivatives of marijuana might be developed for human use, it was clear that the psychoactive effects of these cannabinoids would need to be reduced sufficiently to make them a safe and comfortable treatment for people with MS.”

Although conducted with full research, please do not use this article as medical advice. For more information on Multiple Sclerosis (MS) and the effects of medical marijuana, please consult your Physician.